Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resveratrol Protects Against Pathological Preterm Birth by Suppression of Macrophage-Mediated Inflammation.
Furuya H, Taguchi A, Kawana K, Yamashita A, Inoue E, Yoshida M, Nakamura H, Fujimoto A, Inoue T, Sato M, Nishida H, Nagasaka K, Adachi K, Hoya M, Nagamatsu T, Wada-Hiraike O, Yamashita T, Osuga Y, Fujii T. Furuya H, et al. Among authors: adachi k. Reprod Sci. 2015 Dec;22(12):1561-8. doi: 10.1177/1933719115589413. Epub 2015 Jun 2. Reprod Sci. 2015. PMID: 26037299
Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis.
Fujimoto A, Kawana K, Taguchi A, Adachi K, Sato M, Nakamura H, Ogishima J, Yoshida M, Inoue T, Nishida H, Tomio K, Yamashita A, Matsumoto Y, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Fujimoto A, et al. Among authors: adachi k. Oncotarget. 2016 Aug 9;7(32):51854-51864. doi: 10.18632/oncotarget.10126. Oncotarget. 2016. PMID: 27322083 Free PMC article.
Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
Yoshida M, Taguchi A, Kawana K, Adachi K, Kawata A, Ogishima J, Nakamura H, Fujimoto A, Sato M, Inoue T, Nishida H, Furuya H, Tomio K, Arimoto T, Koga K, Wada-Hiraike O, Oda K, Nagamatsu T, Kiyono T, Osuga Y, Fujii T. Yoshida M, et al. Among authors: adachi k. PLoS One. 2016 Aug 2;11(8):e0160330. doi: 10.1371/journal.pone.0160330. eCollection 2016. PLoS One. 2016. PMID: 27483433 Free PMC article.
Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor.
Inoue T, Adachi K, Kawana K, Taguchi A, Nagamatsu T, Fujimoto A, Tomio K, Yamashita A, Eguchi S, Nishida H, Nakamura H, Sato M, Yoshida M, Arimoto T, Wada-Hiraike O, Oda K, Osuga Y, Fujii T. Inoue T, et al. Among authors: adachi k. Int J Oncol. 2016 Oct;49(4):1297-304. doi: 10.3892/ijo.2016.3631. Epub 2016 Jul 26. Int J Oncol. 2016. PMID: 27499237 Free PMC article.
STAT3 activity regulates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cervical cancer cells.
Nakamura H, Taguchi A, Kawana K, Kawata A, Yoshida M, Fujimoto A, Ogishima J, Sato M, Inoue T, Nishida H, Furuya H, Tomio K, Eguchi S, Mori-Uchino M, Yamashita A, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Nakamura H, et al. Among authors: adachi k. Int J Oncol. 2016 Nov;49(5):2155-2162. doi: 10.3892/ijo.2016.3681. Epub 2016 Sep 6. Int J Oncol. 2016. PMID: 27599897
Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
Nakamura H, Nagasaka K, Kawana K, Taguchi A, Uehara Y, Yoshida M, Sato M, Nishida H, Fujimoto A, Inoue T, Adachi K, Nagamatsu T, Arimoto T, Oda K, Osuga Y, Fujii T. Nakamura H, et al. Among authors: adachi k. BMC Cancer. 2016 Nov 17;16(1):897. doi: 10.1186/s12885-016-2929-2. BMC Cancer. 2016. PMID: 27855669 Free PMC article.
Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.
Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Ogishima J, Eguchi S, Yamashita A, Tomio K, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Sato M, et al. Among authors: adachi k. Oncotarget. 2017 Jun 20;8(25):40935-40945. doi: 10.18632/oncotarget.16783. Oncotarget. 2017. PMID: 28402962 Free PMC article.
Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.
Nakamura H, Taguchi A, Kawana K, Baba S, Kawata A, Yoshida M, Fujimoto A, Ogishima J, Sato M, Inoue T, Nishida H, Furuya H, Yamashita A, Eguchi S, Tomio K, Mori-Uchino M, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Nakamura H, et al. Among authors: adachi k. Oncotarget. 2018 Feb 5;9(17):13451-13461. doi: 10.18632/oncotarget.24413. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568369 Free PMC article.
Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
Yoshida M, Taguchi A, Kawana K, Ogishima J, Adachi K, Kawata A, Nakamura H, Sato M, Fujimoto A, Inoue T, Tomio K, Mori M, Nagamatsu T, Arimoto T, Koga K, Hiraike OW, Oda K, Kiyono T, Osuga Y, Fujii T. Yoshida M, et al. Among authors: adachi k. Int J Oncol. 2018 Oct;53(4):1580-1590. doi: 10.3892/ijo.2018.4504. Epub 2018 Jul 26. Int J Oncol. 2018. PMID: 30066851 Free PMC article.
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway.
Ogishima J, Taguchi A, Kawata A, Kawana K, Yoshida M, Yoshimatsu Y, Sato M, Nakamura H, Kawata Y, Nishijima A, Fujimoto A, Tomio K, Adachi K, Nagamatsu T, Oda K, Kiyono T, Osuga Y, Fujii T. Ogishima J, et al. Among authors: adachi k. BMC Cancer. 2018 Dec 3;18(1):1201. doi: 10.1186/s12885-018-4922-4. BMC Cancer. 2018. PMID: 30509235 Free PMC article.
2,241 results